Posts

4P-Pharma at the 3rd International Symposium Research on Healthy Ageing – Longevity Symposium

A poster on 4P-004 entitled “Protective Effects of Intra-Articular Formulated Liraglutide in Osteoarthritis: Preclinical Studies” will be presented during the 3rd International Symposium Research on Healthy Ageing – Longevity Symposium in Institut Pasteur de Lille, France, December 11th-12th 2019, by our Research Assistant, Coralie Meurot (PhD student).

For further information, please feel free to contact our R&D team, Coralie Meurot, Jérôme Breton and Céline Martin via e-mail.

4P-Pharma presents 4P-004 data at the ACR/ARP Annual Meeting in Atlanta

A poster on 4P-004 entitled “Protective Effects of Intra-Articular Formulated Liraglutide in Osteoarthritis: Preclinical Studies” (#1973) will be presented during the ACR/ARP Annual Meeting in Atlanta, Georgia November 8 – 13, 2019, by Pr. Francis Berenbaum (Professor of Rheumatology at Sorbonne University, in Paris (France)).

For further information, please click on the following link:

 

4P-Pharma dans la Tribune

Revital Rattenbach, Présidente de 4P-Pharma, et le Prof. Francis Berenbaum, Professeur de rhumatologie à Sorbonne Université, présentent dans une interview pour “Paroles d’Experts” de la Tribune, 4P-004, une nouvelle molécule thérapeutique visant à enrayer la progression de l’arthrose en vu d’un développement clinique dès 2020.